Best Practices

BEST PRACTICES: Multiplex Technology Delivers a Novel Tool to Assist in Ruling Out Systemic Lupus Erythematosus

This supplement is sponsored by ImmunArray

 

The diagnosis of systemic lupus erythematosus (SLE) is a complex and potentially prolonged process, sometimes requiring years of monitoring, extensive testing, and consultation. There is no single serologic test or validated biomarker to help clinicians confirm or rule out an SLE diagnosis. Consequently, there is a pressing need for objective diagnostic tools capable of either definitively diagnosing or ruling out a diagnosis of SLE. The SLE-key ® (ImmunArray, Richmond, Virginia) is a new, validated blood test capable of definitively ruling out a diagnosis of SLE in diverse patient populations in routine clinical practice.  This Best Practices supplement provides important information about the SLE-key ® test as well as Questions & Answers from key experts in systemic lupus erythematosus.

Ellen Field, MD  
Private Practice, Rheumatology 
Lehigh Valley, Pennsylvania

Staff, Lehigh Valley Hospital
St. Luke’s Hospital
Sacred Heart Hospital
Lehigh Valley, Pennsylvania

Clinical Assistant Adjunct Professor of Medicine 
Temple University School of Medicine
Philadelphia, Pennsylvania

Q&A with

Peter Rumore, MD
Rheumatology Associates of Long Island
Smithtown, New York
Alan Kivitz, MD
Altoona Arthritis and Osteoporosis Center
Duncansville, Pennsylvania

 

Click here to read this Best Practices supplement

 

 

Recommended for You

News & Commentary

Quizzes from MD-IQ

Research Summaries from ClinicalEdge

Next Article: